Insulin-secreting beta cells are central to any understanding of diabetes. This course examines their physiology and significance in the disease processes of type 1 and type 2 diabetes.
Courses coming soon
One of the greatest discoveries of medical history, insulin has transformed the lives of people with diabetes. This course looks at how research continues to transform our understanding of this medical ‘miracle’ and how it can be used.
Available courses
Lifestyle intervention
From diet and exercise to smoking cessation, lifestyle intervention continues to be a mainstay of diabetes care. This course looks at how to promote lasting behaviour changes for better health.
Diabetic ketoacidosis
This course gives you the tools you need to identify and treat diabetic ketoacidosis (DKA) and to support your patients in avoiding this potentially life-threatening complication.
Diabetes and Ramadan
Using practical case studies and international guidelines, this course introduces you to treating people with type 1 or type 2 diabetes before, during and after Ramadan.
Diabetic neuropathy
Over time, hyperglycaemia can result in damage to the nerves, with severe consequences for health – not just in the feet but all over the body. This course looks at diabetic neuropathy in all its forms.
Therapeutic inertia
Therapeutic inertia has been implicated as a significant contributory factor in suboptimal diabetes management. This course explores the phenomenon – defined as the failure to advance or de-intensify therapy when appropriate.
Hypoglycaemia
This course examines hypoglycaemia, a complication of therapy that has a profound impact on the day-to-day lives and well-being of people who treat their diabetes with insulin.
Metabolic surgery
Surgical intervention to help manage or even reverse type 2 diabetes has gained credence in recent years. This course looks at the theory and the practice.
Obesity and diabetes
This course examines the links between ectopic fat and the onset of type 2 diabetes, and how these in turn fuel cardiovascular and cardiorenal risks.
Non-alcoholic fatty liver disease
In the wake of the diabetes pandemic, prevalence of non-alcoholic fatty liver disease (NAFLD) is on the rise. This course sets out the health implications and potential treatments for this serious but reversible condition.
Real-world evidence
The value attached to real-world evidence (RWE) in clinical decision making has significantly increased in recent years. Using examples taken from diabetes treatment, this course looks at what RWE is, why it is important and who can benefit from it.
Cardiovascular health and diabetes
This course focuses on cardiovascular health – one of the most significant and challenging aspects of care for type 1 and type 2 diabetes.
SGLT-2 inhibitors
From the physiology of renal glucose absorption to key outcome trials, this course provides a detailed introduction to this class of diabetes drugs.
Insulin resistance
As the incidence of type 2 diabetes continues to explode worldwide, this course gets to grips with the maladapted process at its heart: insulin resistance.
GLP-1 receptor agonists
From obscure origins in studies of lizard saliva, GLP-1 receptor agonists (GLP-1RAs) have become a staple of type 2 diabetes treatment. This course examines the ways in which they can aid type 2 diabetes management.
Diabetes and the Hajj
Hajj, the world’s oldest and largest mass gathering, is one of the Five Pillars of Islam. This course considers it in a clinical context, examining how people with diabetes can be supported to perform the rites safely.
Diabetic foot disease
This course outlines key aspects of this important but sometimes neglected complication of diabetes.
Islet transplantation
Transplants of insulin-producing islets offer the hope of glucose regulation without daily insulin injections. This course looks at advances in this exciting field of diabetes treatment and the challenges still to come.
Diabetes and the kidney
This course has been created to introduce you to the diagnosis, consequences and treatment of diabetic kidney disease (diabetic nephropathy).
Phenotypic variability
This course highlights how important an understanding of diabetes in phenotypic terms is to the pursuit of patient-centred care and precision medicine.
Diagnosis of type 1 diabetes
This course has been developed to introduce you to the diagnosis of type 1 diabetes and to explore the possible causes of the condition.
Management of hyperglycaemia in type 2 diabetes
An introduction to the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) 2018 consensus report and its 2019 update.
Technology and type 1 diabetes
In this course, insulin pumps and continuous glucose monitoring are discussed using real life examples to help you understand how this technology works optimally.
Pregestational diabetes in pregnancy
This course introduces you to the treatment and management of women with pre-existing diabetes before, during and after their pregnancy.
The pathogenesis of type 1 diabetes
This course explores the mechanisms by which autoimmune destruction of beta cells results in type 1 diabetes, and looks how the process might be arrested.
Time in range
This course has been created to introduce you to time in range, a new concept in glycaemic management that challenges the role of HbA1c.